BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Del Riccio M, Lorini C, Bonaccorsi G, Paget J, Caini S. The Association between Influenza Vaccination and the Risk of SARS-CoV-2 Infection, Severe Illness, and Death: A Systematic Review of the Literature. Int J Environ Res Public Health 2020;17:E7870. [PMID: 33121070 DOI: 10.3390/ijerph17217870] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Alòs F, Cánovas Zaldúa Y, Feijóo Rodríguez MV, Del Val Garcia JL, Sánchez-callejas A, Colomer MÀ. Does Influenza Vaccination Reduce the Risk of Contracting COVID-19? JCM 2022;11:5297. [DOI: 10.3390/jcm11185297] [Reference Citation Analysis]
2 Alobwede SM, Kidzeru EB, Katoto PDMC, Lumngwena EN, Cooper S, Goliath R, Jackson A, Wiysonge CS, Shey MS. Influenza Vaccination Uptake and Hesitancy among Healthcare Workers in Early 2021 at the Start of the COVID-19 Vaccine Rollout in Cape Town, South Africa. Vaccines (Basel) 2022;10:1176. [PMID: 35893825 DOI: 10.3390/vaccines10081176] [Reference Citation Analysis]
3 Veronese N, Smith L, Di Gennaro F, Bruyère O, Yang L, Demurtas J, Maggi S, Sabico S, Al-daghri NM, Barbagallo M, Dominguez LJ, Koyanagi A. Influenza Vaccination and COVID-19 Outcomes in People Older than 50 Years: Data from the Observational Longitudinal SHARE Study. Vaccines 2022;10:899. [DOI: 10.3390/vaccines10060899] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zeynali Bujani M, Behnampour M, Rahimi N, Safari T, Khazaei Feizabad A, Hossein Sarbazi A, Baniasadi M, Rezaei N, Ansari Moghaddam A. The Effect of Influenza Vaccination on COVID-19 Morbidity, Severity and Mortality: Systematic Review and Meta-Analysis. Malays J Med Sci 2021;28:20-31. [PMID: 35002487 DOI: 10.21315/mjms2021.28.6.3] [Reference Citation Analysis]
5 Domenech de Cellès M, Casalegno JS, Lina B, Opatowski L. Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2. PeerJ 2021;9:e12566. [PMID: 34950537 DOI: 10.7717/peerj.12566] [Reference Citation Analysis]
6 Montalti M, Di Valerio Z, Rallo F, Squillace L, Costantino C, Tomasello F, Mauro GL, Stillo M, Perrone P, Resi D, Gori D, Vitale F, Fantini MP. Attitudes toward the SARS-CoV-2 and Influenza Vaccination in the Metropolitan Cities of Bologna and Palermo, Italy. Vaccines (Basel) 2021;9:1200. [PMID: 34696308 DOI: 10.3390/vaccines9101200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pépin J, De Wals P, Labbé AC, Carignan A, Parent ME, Yu J, Valiquette L, Rousseau MC. Influenza vaccine during the 2019-2020 season and COVID-19 risk: A case-control study in Québec. Can Commun Dis Rep 2021;47:430-4. [PMID: 34737675 DOI: 10.14745/ccdr.v47i10a05] [Reference Citation Analysis]
8 O'Byrne P, Musten A, Vandyk A, Ho N, Orser L, Haines M, Paulin V. HIV self-testing in Ottawa, Canada used by persons at risk for HIV: The GetaKit study. Can Commun Dis Rep 2021;47:435-41. [PMID: 34737676 DOI: 10.14745/ccdr.v47i10a06] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Chiappini E, Parigi S, Galli L, Licari A, Brambilla I, Angela Tosca M, Ciprandi G, Marseglia G. Impact that the COVID-19 pandemic on routine childhood vaccinations and challenges ahead: A narrative review. Acta Paediatr 2021;110:2529-35. [PMID: 34028088 DOI: 10.1111/apa.15949] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
10 Massari M, Spila-Alegiani S, Fabiani M, Belleudi V, Trifirò G, Kirchmayer U, Poggi FR, Mancuso P, Menniti-Ippolito F, Gini R, Bartolini C, Leoni O, Ercolanoni M, Da-Re F, Guzzinati S, Luxi N, Riccardo F, Giorgi-Rossi P. Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study. Vaccines (Basel) 2021;9:716. [PMID: 34358133 DOI: 10.3390/vaccines9070716] [Reference Citation Analysis]
11 King JP, McLean HQ, Belongia EA. Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019-2020 season. Influenza Other Respir Viruses 2021. [PMID: 34169670 DOI: 10.1111/irv.12880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Fernández Ibáñez JM, Morales Ballesteros MDC, Fernández Anguita MJ, Galindo Andúgar MÁ, Arias Arias Á, Barberá-Farré JR. Influence of influenza vaccine and comorbidity on the evolution of hospitalized COVID-19 patients. Med Clin (Barc) 2021:S0025-7753(21)00325-0. [PMID: 34304882 DOI: 10.1016/j.medcli.2021.06.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang R, Liu M, Liu J. The Association between Influenza Vaccination and COVID-19 and Its Outcomes: A Systematic Review and Meta-Analysis of Observational Studies. Vaccines (Basel) 2021;9:529. [PMID: 34065294 DOI: 10.3390/vaccines9050529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pastorino R, Villani L, La Milia DI, Ieraci R, Chini F, Volpe E, Barca A, Fusco D, Laurenti P, Ricciardi W, Boccia S. Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital. Vaccine 2021;39:3493-7. [PMID: 34020813 DOI: 10.1016/j.vaccine.2021.05.015] [Reference Citation Analysis]
15 Root-Bernstein R. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths. Vaccines (Basel) 2021;9:474. [PMID: 34066697 DOI: 10.3390/vaccines9050474] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
16 Kowalska M, Niewiadomska E, Barański K, Kaleta-Pilarska A, Brożek G, Zejda JE. Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland. Vaccines (Basel) 2021;9:415. [PMID: 33919206 DOI: 10.3390/vaccines9050415] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
17 Zejda JE, Brożek GM, Kowalska M, Barański K, Kaleta-Pilarska A, Nowakowski A, Xia Y, Buszman P. Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland. Int J Environ Res Public Health 2021;18:3188. [PMID: 33808716 DOI: 10.3390/ijerph18063188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
18 Chen YC, Chow-In Ko P, Lee WC, Lien WC. Ecological fallacy in COVID-19 epidemiological inference: Influenza vaccination rate as an example. J Formos Med Assoc 2021;120:1655-6. [PMID: 33781655 DOI: 10.1016/j.jfma.2021.03.011] [Reference Citation Analysis]
19 Kissling E, Hooiveld M, Brytting M, Vilcu AM, de Lange M, Martínez-Baz I, Sigerson D, Enkirch T, Belhillil S, Meijer A, Castilla J, William N, Carnahan A, Falchi A, Hendriksen J, Casado I, Murray J, Enouf V, Dijkstra F, Marques DFP, Valenciano M. Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020. Influenza Other Respir Viruses 2021;15:429-38. [PMID: 33481344 DOI: 10.1111/irv.12839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Stefanati A, d'Anchera E, De Motoli F, Savio M, Toffoletto MV, Gabutti G. Value of Immunizations during the COVID-19 Emergency. Int J Environ Res Public Health 2021;18:E778. [PMID: 33477591 DOI: 10.3390/ijerph18020778] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Wang X, Kulkarni D, Dozier M, Hartnup K, Paget J, Campbell H, Nair H; Usher Network for COVID-19 Evidence Reviews (UNCOVER) group. Influenza vaccination strategies for 2020-21 in the context of COVID-19. J Glob Health 2020;10:021102. [PMID: 33312512 DOI: 10.7189/jogh.10.021102] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Gatti M, Raschi E, Moretti U, Ardizzoni A, Poluzzi E, Diemberger I. Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel) 2021;9:19. [PMID: 33406694 DOI: 10.3390/vaccines9010019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]